Sandbox spb2013: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) |
Gerald Chi (talk | contribs) mNo edit summary |
||
Line 34: | Line 34: | ||
| colspan="1" style="text-align:center; background:LightGreen"|[[ESA guidelines classification scheme#Classification of Recommendations|Class 1]] | | colspan="1" style="text-align:center; background:LightGreen"|[[ESA guidelines classification scheme#Classification of Recommendations|Class 1]] | ||
|- | |- | ||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.''' We recommend that acute variceal bleeding should be managed by a multidisciplinary team. A specific multimodal protocol for upper gastrointestinal | | bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.''' We recommend that acute [[variceal bleeding]] should be managed by a multidisciplinary team. A specific multimodal protocol for [[upper gastrointestinal hemorrhage]] should be available.. ''([[ESA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])''<nowiki>"</nowiki> | ||
|- | |- | ||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''2.''' We recommend that early treatment involves immediate use of | | bgcolor="LightGreen"|<nowiki>"</nowiki>'''2.''' We recommend that early treatment involves immediate use of [[vasopressor]]s ([[somatostatin]] or [[terlipressin]]) to reduce [[bleeding]] and early interventional [[endoscopy]]. [[Antibiotic]]s must be started on admission. ''([[ESA guidelines classification scheme#Level of Evidence|Level of Evidence: A]])''<nowiki>"</nowiki> | ||
|- | |- | ||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''3.''' rFVIIa should be used only as rescue therapy; we recommend against its routine use. ''([[ESA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])''<nowiki>"</nowiki> | | bgcolor="LightGreen"|<nowiki>"</nowiki>'''3.''' rFVIIa should be used only as rescue therapy; we recommend against its routine use. ''([[ESA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])''<nowiki>"</nowiki> | ||
|} | |} | ||
===Coagulopathy and Renal Disease=== | |||
{|class="wikitable" style="width: 80%;" | |||
|- | |||
| colspan="1" style="text-align:center; background:LemonChiffon"|[[ESA guidelines classification scheme#Classification of Recommendations|Class 2]] | |||
|- | |||
| bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1.''' We suggest that conjugated [[estrogen]] therapy should be used in [[uremia]].''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])''<nowiki>"</nowiki> | |||
|- | |||
| bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''2.''' We suggest that [[desmopressin]] should be considered for reducing [[bleeding]] during [[surgery]] and for managing acute [[bleeding]] in [[uremic]] patients.''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])''<nowiki>"</nowiki> | |||
|} | |||
==Sources== | ==Sources== |
Revision as of 15:09, 21 April 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
2013 ESA Guidelines for the Management of Severe Perioperative Bleeding (DO NOT EDIT)[1]
Class 1 |
"1. XXXXX. (Level of Evidence: A)" |
Class 1 |
"1. XXXXX. (Level of Evidence: A)" |
Class 2 |
"1. XXXXX.(Level of Evidence: A)" |
2013 ESA Guidelines for the Management of Severe Perioperative Bleeding (DO NOT EDIT)[1]
Acute Upper Gastrointestinal Bleeding
Class 1 |
"1. We recommend that acute variceal bleeding should be managed by a multidisciplinary team. A specific multimodal protocol for upper gastrointestinal hemorrhage should be available.. (Level of Evidence: C)" |
"2. We recommend that early treatment involves immediate use of vasopressors (somatostatin or terlipressin) to reduce bleeding and early interventional endoscopy. Antibiotics must be started on admission. (Level of Evidence: A)" |
"3. rFVIIa should be used only as rescue therapy; we recommend against its routine use. (Level of Evidence: C)" |
Coagulopathy and Renal Disease
Class 2 |
"1. We suggest that conjugated estrogen therapy should be used in uremia.(Level of Evidence: C)" |
"2. We suggest that desmopressin should be considered for reducing bleeding during surgery and for managing acute bleeding in uremic patients.(Level of Evidence: C)" |
Sources
- 2013 ESA Guidelines for the Management of Severe Perioperative Bleeding[1]
References
- ↑ 1.0 1.1 1.2 Kozek-Langenecker, SA.; Afshari, A.; Albaladejo, P.; Santullano, CA.; De Robertis, E.; Filipescu, DC.; Fries, D.; Görlinger, K.; Haas, T. (2013). "Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology". Eur J Anaesthesiol. 30 (6): 270–382. doi:10.1097/EJA.0b013e32835f4d5b. PMID 23656742. Unknown parameter
|month=
ignored (help)